Triglyceride reduction in secondary atherosclerotic cardiovascular disease prevention: core concepts in contemporary therapeutic targeting

Eur Heart J. 2020 Apr 14;41(15):1521-1522. doi: 10.1093/eurheartj/ehaa078.

Authors

Patrick R Lawler^{1

2

3}, Robert S Rosenson⁴, Dennis T Ko^{3

5}

Affiliations

¹ Peter Munk Cardiac Centre, University Health Network, 200 Elizabeth St, Toronto, Ontario M5G2C4, Canada.
² Ted Rogers Centre for Heart Research, 661 University Avenue, 14th Floor, Toronto, Ontario M5G 1M1, Canada.
³ University of Toronto, 27 King's College Cir, Toronto, Ontario M5S 1K1, Canada.
⁴ Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1030, New York, NY 10029-6574, USA.
⁵ ICES, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada.

PMID: 32154871
DOI: 10.1093/eurheartj/ehaa078

No abstract available

Publication types

Comment

MeSH terms

Atherosclerosis* / drug therapy
Atherosclerosis* / prevention & control
Cardiovascular Diseases* / prevention & control
Cardiovascular System*
Humans
Hypertriglyceridemia*
Triglycerides

Substances

Triglycerides